April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Visual acuity at presentation in the second eye versus first eye in patients affected with exudative age-related macular degeneration
Author Affiliations & Notes
  • Olivier Chevreaud
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Rocio Blanco-Garavito
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Giuseppe Querques
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Nathalie Puche
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Oudy Semoun
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Benedicte Merle
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Camille Jung
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Eric H Souied
    Centre Hospitalier Intercommunal de Créteil, Créteil, France
  • Footnotes
    Commercial Relationships Olivier Chevreaud, None; Rocio Blanco-Garavito, None; Giuseppe Querques, None; Nathalie Puche, None; Oudy Semoun, None; Benedicte Merle, None; Camille Jung, None; Eric Souied, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 648. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Olivier Chevreaud, Rocio Blanco-Garavito, Giuseppe Querques, Nathalie Puche, Oudy Semoun, Benedicte Merle, Camille Jung, Eric H Souied; Visual acuity at presentation in the second eye versus first eye in patients affected with exudative age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2014;55(13):648.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract 
 
Purpose
 

To assess the difference in best-corrected visual acuity (BCVA) at diagnosis between first and second eye in patients suffering from bilateral neovascular age-related macular degeneration (AMD).

 
Methods
 

We reviewed the charts of all patients that had a clinical examination for neovascular AMD in the University Eye Clinic of Creteil in January 2013. We retrospectively analyzed demographic and clinical data for 264 patients.

 
Results
 

75/264 patients (28.4%) developed choroidal neovascularization (CNV) in the felloweye with a time interval between the two events of 30.3 months (standard deviation (SD): 27.7). The mean BCVA at diagnosis of the first eye involved was 0.68 (SD: 0.41) logarithm ofminimum angle of resolution (logMAR) and the mean BCVA for the second eye was 0.36 (SD: 0.29) logMAR (p<0.0001). When diagnosingg CNV in the second eye, 14/75 patients (18.7%) were asymptomatic, CNV being detected thanks to systematic examination performed as routine management of the first eye.

 
Conclusions
 

Compared to visual acuity in the first eye at the time of diagnosis of active CNV, we found that visual acuity in the second eye was better, this was possibly due to several factors, including changes in follow up care. Moreover 18, 7% of the patients were asymptomatic, which highlights the importance of the screening of the fellow eye in neovascular AMD.

 
Keywords: 412 age-related macular degeneration • 754 visual acuity  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×